Comparison of the prognostic significance of the Shimada classification and N-myc copy number in neuroblastoma: A prospective study

International Journal of Oncology

Volumn 8, Issue 2, 1996, Pages 343-347

  Savilo, Elena ^a   Harnish, Delsworth G ^a   Desa, Derek ^a   Willan, Andrew ^a   Barr, Ronald D ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Histopathology; N myc; Neuroblastoma; Prognosis

Indexed keywords

ARTICLE; CHILD; CLASSIFICATION; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; INFANT; MALE; NEUROBLASTOMA; PRIORITY JOURNAL; PROTO ONCOGENE; SOUTHERN BLOTTING;

EID: 0030051513     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Evans AE, D'Angio GJ and Randolph J: A proposed staging for children with neuroblastoma. Children's Cancer Study Group A. Cancer 27: 374-378, 1971.
2. Berthold F, Hunneman DH, Harms D, Kaser H and Zieschang J: Serum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblastoma. Eur J Cancer 28A: 1950-1954, 1992.
3. Shimada H, Chatten J, Newton WA, Sachs N, Hamoudi A, Chiba T, Marsden H and Misugi K: Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and age-linked classification of neuroblastomas. J Natl Cancer Inst 73: 405-416, 1984.
4. Joshi VV, Silverman JF, Altshuler G, Cantor AB, Larkin EW, Neill JS, Norris HT, Shuster JJ, Holbrook CT, Hayes FA, Smith E and Castleberry R: Systematization of primary histopathologic and fine-needle aspiration cytologic features and description of unusual histopathologic features of neuroblastic tumors: a report from the Pediatric Oncology Group. Hum Pathol 24: 493-504, 1993.
5. Hayashi Y, Kanda N, Inaba T, Hanada R, Nahgahara R, Muchi H and Yamamoto K: Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer 63: 126-132, 1989.
6. Schwab M: Molecular cytogenetics of human neuroblastoma. Biochim Biophys Acta 1114: 43-50, 1992.
7. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB and Brodeur GM: Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 328: 847-854, 1993.
8. Brodeur GM, Seeger RC, Schwab M, Varmus HE and Bishop JM: Amplification of N-myc in untreated human neuroblastomas correlate with advanced disease stage. Science 224: 1121-1124, 1984.